Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Naltrexone/bupropion for binge‐eating disorder: A randomized, double‐blind, placebo‐controlled trial

Obesity(2023)10.1002/oby.23898Source: DataRank Database

Naltrexone/bupropion for binge‐eating disorder: A randomized, double‐blind, placebo‐controlled trial is a research paper published in Obesity (2023). On theSindex it has a DataRank of 0. It has been cited 47 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access47 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 12.79)OA: greenTopics (42)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Janet A. Lydecker ORCID,Ania M. Jastreboff ORCID,Brian Pittman ORCID,Sherry A. McKee ORCID,Carlos M. Grilo ORCID

Live enrichment

PubMed:37751990 PMC:PMC10600891 OpenAlex:https://openalex.org/W4387036146

National Institute of Diabetes and Digestive and Kidney Diseases

Grant: R01 DK112771

National Institute of Diabetes and Digestive and Kidney Diseases

Grant: K23‐DK‐115893

National Institute of Diabetes and Digestive and Kidney Diseases

Grant: UL1‐TR‐001863

NIDDK NIH HHS

Grant: K23 DK115893

NCATS NIH HHS

Grant: UL1 TR001863

FWCI

12.79

Citation Percentile

1.0%

Citation Trend

2023

2024

2025

2026

greenLicense: http://onlinelibrary.wiley.com/termsAndConditions#vor

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10600891/pdf/nihms-1938836.pdf

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/oby.23898

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/10600891

journalhttps://doi.org/10.1002/oby.23898

Fields of Study

Eating Disorders and BehaviorsBariatric Surgery and OutcomesPharmacology and Obesity TreatmentHumansFemaleMiddle AgedMaleBupropionNaltrexoneBinge-Eating DisorderObesityBulimiaWeight LossDouble-Blind MethodTreatment Outcome

MeSH Terms

BulimiaDouble-Blind MethodFemaleHumansMaleMiddle AgedNaltrexoneObesityWeight LossBupropionTreatment OutcomeBinge-Eating Disorder

Keywords

NaltrexoneBupropionPlaceboMedicineInternal medicineBinge eatingBinge-eating disorderRandomized controlled trialRandomizationObesityPsychiatryEating disordersBulimia nervosaSmoking cessationAntagonist

Sustainable Development Goals

SDG 0: Good health and well-being